✦ LIBER ✦

Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: A phase II trial

✍ Scribed by Levi S. Downs Jr.; Justin C. Chura; Peter A. Argenta; Patricia L. Judson; Rahel Ghebre; Melissa A. Geller; Linda F. Carson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of ifosfamide and cis-pla

✍ M. Rodriguez; K. Look; M. Callagan; G. Sutton 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Phase II trial of nab-paclitaxel in the

✍ David S. Alberts; John A. Blessing; Lisa M. Landrum; David P. Warshal; Lainie P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 209 KB

A Phase II Study of Carboplatin and Cisp

✍ Mitchell Morris; David M. Gershenson; Thomas W. Burke; Michele Follen Mitchell; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Phase II trial of ifosfamide and mesna i

✍ G. Sutton; J. Blessing; W. McGuire; T. Patton 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 159 KB

A Phase II Trial of Carboplatin and Etop

✍ Niall Tebbutt; Danny Rischin; Michael Quinn; Robert Rome; Michael J. Millward; G 📂 Article 📅 1998 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 395 KB

A multi-institutional phase II trial of

✍ Ryo Kitagawa; Noriyuki Katsumata; Masashi Ando; Chikako Shimizu; Yasuhiro Fujiwa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 220 KB